Citizen Health and Rocket Pharma Unite to Transform Patient Outcomes in Rare Cardiomyopathy Treatment Citizen Health's partnership with Rocket Pharma focuses on enhancing drug development and patient experiences in treating PKP2 Cardiomyopathy, a rare heart condition.

Citizen Health and Rocket Pharma Unite to Transform Patient Outcomes in Rare Cardiomyopathy Treatment #USA #San_Francisco #Rocket_Pharma #Citizen_Health #PKP2_Cardiomyopathy